Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Medical Genome Facility, Proteomics Core, Mayo Clinic, Rochester, Minnesota.
J Am Soc Nephrol. 2021 May 3;32(5):1249-1261. doi: 10.1681/ASN.2020081165. Epub 2021 Apr 8.
Membranous nephropathy (MN) results from deposition of antigen-antibody complexes along the glomerular basement membrane (GBM). PLA2R, THSD7A, NELL1, and SEMA3B account for 80%-90% of target antigens in MN.
We performed laser microdissection and mass spectrometry (MS/MS) in kidney biopsies from 135 individuals with PLA2R-negative MN, and used immunohistochemistry/immunofluorescence and confocal microscopy to confirm the MS/MS finding, detect additional cases, and localize the novel protein. We also performed MS/MS and immunohistochemistry on 116 controls and used immunofluorescence microscopy to screen biopsy samples from two validation cohorts. Western blot and elution studies were performed to detect antibodies in serum and biopsy tissue.
MS/MS studies detected a unique protein, protocadherin 7 (PCDH7), in glomeruli of ten (5.7%) PLA2R-negative MN cases, which also were negative for PLA2R, THSD7A, EXT1/EXT2, NELL1, and SEMA3B. Spectral counts ranged from six to 24 (average 13.2 [SD 6.6]). MS/MS did not detect PCDH7 in controls (which included 28 PLA2R-positive cases). In all ten PCDH7-positive cases, immunohistochemistry showed bright granular staining along the GBM, which was absent in the remaining cases of PLA2R-negative MN and control cases. Four of 69 (5.8%) cases in the validation cohorts (all of which were negative for PLA2R, THSD7A, EXT1, NELL1, and SEMA3B) were PCDH7-positive MN. Kidney biopsy showed minimal complement deposition in 12 of the 14 PCDH7-associated cases. Confocal microscopy showed colocalization of PCDH7 and IgG along the GBM. Western blot analysis using sera from six patients showed antibodies to nonreduced PCDH7. Elution of IgG from frozen tissue of PCDH7-associated MN showed reactivity against PCDH7.
MN associated with the protocadherin PCDH7 appears to be a distinct, previously unidentified type of MN.
膜性肾病(MN)是由抗原-抗体复合物沿肾小球基底膜(GBM)沉积引起的。PLA2R、THSD7A、NELL1 和 SEMA3B 占 MN 靶抗原的 80%-90%。
我们对 135 例 PLA2R 阴性 MN 患者的肾活检组织进行激光显微切割和质谱(MS/MS)分析,并使用免疫组织化学/免疫荧光和共聚焦显微镜证实 MS/MS 发现、检测额外病例并定位新蛋白。我们还对 116 例对照进行了 MS/MS 和免疫组织化学分析,并使用免疫荧光显微镜筛选两个验证队列的活检样本。Western blot 和洗脱研究用于检测血清和活检组织中的抗体。
MS/MS 研究在 10 例(5.7%)PLA2R 阴性 MN 病例的肾小球中检测到一种独特的蛋白原钙黏蛋白 7(PCDH7),这些病例也均为 PLA2R、THSD7A、EXT1/EXT2、NELL1 和 SEMA3B 阴性。谱计数范围为 6 到 24(平均 13.2[SD 6.6])。MS/MS 在对照组(包括 28 例 PLA2R 阳性病例)中未检测到 PCDH7。在所有 10 例 PCDH7 阳性病例中,免疫组织化学显示沿 GBM 呈明亮的颗粒状染色,而在其余 PLA2R 阴性 MN 和对照组病例中则不存在。在验证队列的 69 例(4 例为 PCDH7 阳性 MN)中,4 例(5.8%)为 PCDH7 阳性。14 例 PCDH7 相关病例中,12 例肾活检显示最小的补体沉积。共聚焦显微镜显示 PCDH7 和 IgG 沿 GBM 共定位。使用来自 6 例患者的血清进行的 Western blot 分析显示针对非还原型 PCDH7 的抗体。从 PCDH7 相关 MN 的冷冻组织洗脱 IgG 显示针对 PCDH7 的反应性。
与原钙黏蛋白 PCDH7 相关的 MN 似乎是一种独特的、以前未识别的 MN 类型。